Matthew Roberts
Overview
Explore the profile of Matthew Roberts including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
111
Citations
1154
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Daynes E, Evans R, Greening N, Bishop N, Yates T, Lozano-Rojas D, et al.
Eur Respir J
. 2025 Feb;
PMID: 39978856
Objective: Post-COVID syndrome involves prolonged symptoms with multi-system and functional impairment lasting at least 12 weeks after acute COVID-19. We aimed to determine the efficacy of exercise-based rehabilitation interventions, either...
2.
Kolovos P, Davies C, Kholmurodova F, Irish G, Kulkarni H, Polkinghorne K, et al.
Intern Med J
. 2025 Jan;
PMID: 39797598
Background And Aims: The COVID-19 pandemic impacted greatest among patients with pre-existing chronic health conditions, including chronic kidney disease. This retrospective cohort study aimed to investigate the 30-day mortality of...
3.
Moore B, Daniels K, Martinez B, Sexton K, Kalkwarf K, Roberts M, et al.
J Surg Res
. 2024 Nov;
PMID: 39490383
Introduction: Intensive care unit (ICU) readmissions are associated with increased morbidity and mortality rates, longer hospitalization, and increased health-care expenditures. This study sought to present a large cohort of trauma...
4.
Aziz M, Molony D, Monlezun D, Holder T, Brunckhorst O, Higgason N, et al.
Eur Urol
. 2024 Sep;
87(1):15-26.
PMID: 39299896
Background And Objective: Recommendations of first-line therapies for metastatic hormone-sensitive (mHSPC), nonmetastatic castrate-resistant (M0CRPC), and metastatic castrate-resistant (mCRPC) prostate cancer do not account for cardiotoxicity due to a lack of...
5.
Haghdoost M, Young S, Holloway A, Roberts M, Zvorsky I, Bonn-Miller M
Int J Mol Sci
. 2024 Jul;
25(14).
PMID: 39062976
Phytocannabinoids with seven-carbon alkyl chains (phorols) have gained a lot of attention, as they are commonly believed to be more potent versions of typical cannabinoids with shorter alkyl chains. At...
6.
Haghdoost M, Young S, Roberts M, Krebs C, Bonn-Miller M
Biomedicines
. 2024 Jul;
12(7).
PMID: 39062125
Cannabielsoin (CBE) is primarily recognized as an oxidation byproduct of cannabidiol (CBD) and a minor mammalian metabolite of CBD. The pharmacological interactions between CBE and cannabinoid receptors remain largely unexplored,...
7.
Haghdoost M, Peters E, Roberts M, Bonn-Miller M
Cannabis Cannabinoid Res
. 2024 Jul;
10(1):1-5.
PMID: 38995871
Tetrahydrocannabivarin (THCV) is a phytocannabinoid that is becoming popular across the North American cannabis market. THCV has been reported to reduce blood sugar and act as an appetite suppressant in...
8.
Haghdoost M, Lopez de Los Santos Y, Brunstetter M, Ferretti M, Roberts M, Bonn-Miller M
Pharmaceuticals (Basel)
. 2024 May;
17(5).
PMID: 38794207
Even slight structural differences between phytocannabinoid isomers are usually enough to cause a change in their biological properties. In this study, we used in vitro CB1 agonism/antagonism assays to compare...
9.
Emmett L, Papa N, Hope T, Fendler W, Calais J, Burger I, et al.
J Urol
. 2024 May;
212(2):299-309.
PMID: 38758680
Purpose: The Prostate Imaging Reporting and Data System (PI-RADS) score is standard of care for clinically significant prostate cancer (csPCa) diagnosis. The PRIMARY score (prostate-specific membrane antigen [PSMA]-positron emission tomography...
10.
Ehtezazi T, Kteich A, Abdulkarim R, Anderson V, Algellay M, McCloskey A, et al.
J Pharm Sci
. 2024 Apr;
113(8):2374-2382.
PMID: 38621439
Oral thrush and throat infections can occur in a wide range of patients. Treatments are available; however, resistance to drugs is a major problem for treating oral and throat infections....